| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |